PERIPHERAL AND BONE MARROW G-CSF-RELATED MYELOBLASTS RATE IN A PATIENT WITH SEVERE CONGENITAL NEUTROPENIA

by Irene Trambusti, Francesco Pegoraro, Marco Tellini, Annalisa Tondo, Marinella Veltroni
Published 2023-12-01

Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

by Barbara Castelli, Barbara Castelli, Carla Fonte, Milena Guidi, Milena Guidi, Marco Tellini, Marco Di Nicola, Alessandro Iacono, Anna Maria Buccoliero, Daniela Greto, Lorenzo Genitori, Iacopo Sardi
Published 2024-02-01

Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

by Barbara Castelli, Barbara Castelli, Carla Fonte, Milena Guidi, Milena Guidi, Marco Tellini, Marco Di Nicola, Alessandro Iacono, Anna Maria Buccoliero, Daniela Greto, Lorenzo Genitori, Iacopo Sardi
Published 2023-09-01

Case report: complete long-lasting response to multimodal third line treatment with neurosurgical resection, carmustine wafer implantation and dabrafenib plus trametinib in a BRAFV...

by Barbara Castelli, Marco Tellini, Melina Guidi, Marco Di Nicola, Laura Giunti, Anna Maria Buccoliero, Maria Luigia Censullo, Alessandro Iacono, Isacco Desideri, Lorenzo Genitori, Iacopo Sardi, Carla Fonte
Published 2024-05-01

Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study

by Ebe Schiavo, Beatrice Martini, Enrico Attardi, Filippo Consonni, Sara Ciullini Mannurita, Maria Luisa Coniglio, Marco Tellini, Elena Chiocca, Ilaria Fotzi, Laura Luti, Irene D’Alba, Marinella Veltroni, Claudio Favre, Eleonora Gambineri, Eleonora Gambineri
Published 2022-01-01